Clinical Trials Logo

Filter by:
NCT ID: NCT00922363 Completed - Tuberculosis Clinical Trials

Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers

Start date: October 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety profile of CAF01, administering 50 µg Ag85B-ESAT-6 alone and 50 µg Ag85B-ESAT-6 with three escalating CAF01 dose levels, to four groups of healthy volunteers, injecting two doses with two months interval.

NCT ID: NCT00922103 Completed - Surgery Clinical Trials

A Study to Investigate the Ileo Neo Rectal Anastomosis Compared to the Ileo Pouch Anal Anastomosis for Patients With Ulcerative Colitis

Start date: June 2005
Phase: N/A
Study type: Interventional

For patients with ulcerative colitis, eligible for surgical treatment, which restorative surgical procedure: the standard ileo pouch anal anastomosis or the alternative ileo neo rectal anastomosis is the best in terms of complications, functional outcome and health status and quality of life.

NCT ID: NCT00921193 Completed - Prostate Cancer Clinical Trials

Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer

Start date: May 2009
Phase: N/A
Study type: Interventional

The study aims to evaluate the safety and performance of the RTPS in patients with localized prostate cancer.The RTPS is an investigational device and requires permanent implantation of a small radioactive fiducial, called the Blip, in the prostate.

NCT ID: NCT00919269 Completed - Rhabdomyosarcoma Clinical Trials

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Start date: March 15, 1999
Phase:
Study type: Observational

The purpose of this study is to collect and store tumor tissue, blood, and bone marrow samples from patients with soft tissue sarcoma that will be tested in the laboratory. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients to test in the laboratory may help the study of cancer.

NCT ID: NCT00918918 Completed - Inflammation Clinical Trials

Effect of Alcohol Consumption on Markers of Inflammation

AR23
Start date: August 2009
Phase: N/A
Study type: Interventional

Rationale: High-density lipoprotein (HDL), which is consistently increased after moderate alcohol consumption, is an abundant plasma lipoprotein that is generally thought to be anti-inflammatory in both health and infectious disease. HDL binds and neutralizes the bioactivity of potent bacterial remnants such as lipopolysaccharides (LPS) which stimulate the host innate immune responses. Primary objective: To explore whether prolonged moderate alcohol consumption affects in vivo cytokine response after a low dose of LPS in young, normal-weight men.

NCT ID: NCT00918255 Completed - Clinical trials for Hidradenitis Suppurativa

Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa

Start date: April 2009
Phase: Phase 2
Study type: Interventional

This study will investigate how well adalimumab works in people with hidradenitis suppurativa (HS) in the short and long term.

NCT ID: NCT00917878 Completed - Inflammation Clinical Trials

Postprandial Effects of Milk and Milk Constituents

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the addition of milk or the milk constituents calcium and protein to a high-fat breakfast affects the postprandial lipid and inflammatory response.

NCT ID: NCT00917046 Completed - Heart Failure Clinical Trials

The SMARTEX Heart Failure Study

SMARTEX
Start date: January 2009
Phase: N/A
Study type: Interventional

This protocol describes a randomized multicenter clinical trial designed to test the hypothesis that a 12-week program of high-intensity interval training (HIIT) yields larger beneficial effects in stable heart failure patients than current practice, defined as either a similar training program with the same volume of moderate continuous training (MCT) or a recommendation of regular exercise at moderate intensity at individual choice (RRE).

NCT ID: NCT00916513 Completed - Diabetes Clinical Trials

Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey

PANORAMA
Start date: May 2009
Phase: N/A
Study type: Observational

The present European survey seeks to assess quality of life and satisfaction with treatment in people with T2DM and to appreciate disease and treatment variables including hypoglycaemia and level of glycaemic control. It will also provide relevant information on other important aspects such as the level of correlation of objective measures such as HbA1c with health status, QoL and satisfaction with current treatment. Overall 5000 randomly selected patients will be invited to participate from a representative sample of clinical practices during a pre-specified period. The study will entail a single patient visit. Patients who agree to the study and give their informed consent will complete questionnaires which, combined with retrospective notes review & an HbA1c test, will allow patient, disease and treatment variables to be collected. An HbA1c test is a finger prick test to measure glycosylated haemoglobin in the blood indicating the level of blood glucose over the last 8-12 weeks.

NCT ID: NCT00916448 Completed - Sepsis Clinical Trials

The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia

Start date: May 2009
Phase: N/A
Study type: Interventional

Excessive inflammation, production of free radicals and vascular injury are considered the main contributors to the development of organ dysfunction in patients with severe infections and sepsis. The endogenously produced unconjugated bilirubin is one of the most powerful anti-oxidants of the human body and the administration of bilirubin in animal experiments has been shown to protect from inflammation-induced death. However, bilirubin for human administration is not yet available. Therefore, we wish to exploit one of the side effects of atazanavir, a registered drug currently used as a protease inhibitor in HIV infected patients. Atazanavir inhibits the enzyme UPD glucuronosyl transferase enzyme (UGT1A1) and therefore increases endogenously produced bilirubin levels moderately. To study the effect of hyperbilirubinemia during inflammation we will apply the human endotoxemia model. The human endotoxemia model permits elucidation of key players in the immune response to a gram negative stimulus in vivo, therefore serving as a useful tool to investigate potential novel therapeutic strategies in a standardized setting. We hypothesize that atazanavir-induced hyperbilirubinemia has beneficial anti-inflammatory and vascular effects during human endotoxemia.